Amarin Corporation PLC at Cowen Health Care Conference Transcript
Good morning, everyone, and welcome to Cowen's 2019 Health Care Conference. My name is Irina Margine. I'm on the Biotech Equity Research Team.
And it is my pleasure to introduce this morning, John Thero, CEO of Amarin.
Thank you for that introduction. And thanks, everybody, for joining me here this morning. We've made a lot of progress since Cowen's last Health Care Conference, and I think we'll make a lot of progress between now and next Cowen's Health Care Conference. And since I've already jumped into forward-looking statements, I will disclaim that there are risks involved with all such statements, anybody considering investing should review our risk factors as filed in our SEC statements.
So Amarin is in the cardiovascular space and, cardiovascular disease, as hopefully you know, is an enormous and worsening public health burden. We see an urgent need and that, the current solutions out
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
